Page last updated: 2024-09-04

glucagon and incretins

glucagon has been researched along with incretins in 164 studies

Compound Research Comparison

Studies (glucagon)	Trials (glucagon)	Recent Studies (post-2010) (glucagon)	Studies (incretins)	Trials (incretins)	Recent Studies (post-2010) (incretins)
26,039	1,498	3,054	2,373	249	1,914

Research

Studies (164)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	18 (10.98)	29.6817
2010's	115 (70.12)	24.3611
2020's	31 (18.90)	2.80

Authors

Authors	Studies
Holst, JJ; Højberg, PV; Knop, FK; Krarup, T; Larsen, S; Madsbad, S; Vilsbøll, T	1
Cassidy, RS; Flatt, PR; Gault, VA; Holst, JJ; Irwin, N; McClean, PL	1
Baz-Hecht, M; Bernier, R; Devine, E; Goldfine, AB; Holst, JJ; Jones, DB; Mun, EC; Patti, ME; Schneider, BE	1
McIntosh, CH	1
Baller, B; Ellrichmann, M; Holst, JJ; Meier, JJ; Nauck, MA; Schmidt, WE; Vollmer, K	1
Bawa, B; Colarusso, A; Egger, JR; Koshy, N; Kovack, B; Laferrère, B; Lee, H; McGinty, J; Olivan, B; Teixeira, J; Tran, H; Yapp, K	1
Ahrén, B; Carr, RD; Deacon, CF; Jelic, K; Larsen, MO; Lindgren, O; Winzell, MS	1
Debaty, I; Halimi, S; Muller, M; Villaret, L	1
Hoist, JJ; Lasalle, JR	1
Girard, J	1
Bianchi, C; Gentilella, R; Rossi, A; Rotella, CM	1
Pratley, RE	1
Ahrén, B; Carr, RD; Deacon, CF; Lindgren, O; Mari, A; Vikman, J; Winzell, MS	1
Besanko, LK; Burgstad, CM; Chapman, MJ; Deane, AM; Fraser, RJ; Horowitz, M	1
Astrup, A; Brader, L; de Vrese, M; Hermansen, K; Holm, L; Holst, JJ; Mortensen, L; Schrezenmeir, J; Thomsen, C	1
Gandhi, GY; Kovalaske, MA	1
Beglinger, C; Castelli, MC; Drewe, J; Friedman, K; Huber, AR; Poller, B; Steinert, RE	1
Gallwitz, B; Thornberry, NA	1
Dirksen, C; Hansen, DL; Holst, JJ; Hvolris, LE; Madsbad, S; Naver, LS; Worm, D	1
Luft, FC	1
Diamant, M; van Genugten, RE; van Raalte, DH	1
Bagger, JI; Hansen, KB; Holst, JJ; Knop, FK; Vilsbøll, T	2
Deacon, CF; Holst, JJ; Jacob, A; Meier, JJ; Menge, BA; Nauck, MA; Ritter, PR; Schmidt, WE	1
Bellon, M; Fraser, RJ; Holloway, RH; Horowitz, M; Jones, KL; Kuo, P; Rayner, CK; Smout, AJ; Wishart, JM	1
Degerblad, M; Edholm, T; Efendic, S; Grybäck, P; Hellström, PM; Hilsted, L; Holst, JJ; Jacobsson, H; Schmidt, PT	1
Svec, F	1
Arias, S; Bawa, B; Bose, M; Laferrère, B; Machineni, S; Olivan, B; Pi-Sunyer, FX; Scherer, PE; Teixeira, J	1
Garber, AJ	1
Campbell, RK; Cobble, ME; Reid, TS; Shomali, ME	4
Asmar, M	1
Sandoval, DA; Tong, J	1
Bagger, JI; Holst, JJ; Knop, FK; Lund, A; Vilsbøll, T	1
Chapman, I; Greville, H; Hetzel, D; Horowitz, M; Jones, KL; Kuo, P; Maddox, A; Rayner, CK; Russo, A; Stevens, JE; Wishart, JM	1
Ali, S; Charron, MJ; Drucker, DJ; Lamont, BJ	1
Damm, P; Nolan, CJ; Prentki, M	1
Irwin, DM; Prentice, KJ	1
Christensen, M; de Heer, J; Holst, JJ; Kielgast, U; Knop, FK; Lund, A; Svendsen, B	1
Aaboe, K; Holst, JJ; Knop, FK; Krarup, T; Madsbad, S; Vilsbøll, T; Vølund, A	1
Kishimoto, M; Noda, M	1
Gjedsted, J; Juhl, CB; Nielsen, MF; Schmitz, O	1
Allister, EM; Bhattacharjee, A; Wheeler, MB	1
Carneiro, L; Derani, A; Göke, B; Schirra, J; Woerle, HJ	1
Castagneto-Gissey, L; Mingrone, G	1
Færch, K; Hansen, T; Holst, JJ; Jørgensen, T; Knop, FK; Pedersen, O; Pilgaard, K	1
Cao, X; Drucker, DJ; Flock, GB; Maziarz, M	1
Deacon, CF; Diamant, M; Heine, RJ; Holst, JJ; Karemaker, JM; Kwa, KA; Mari, A; Tushuizen, ME; van Genugten, RE; van Raalte, DH	1
Aoki, K; Kamiyama, H; Masuda, K; Terauchi, Y; Togashi, Y	1
Chen, C; Chen, Z; Han, Y; Shen, J; Zhu, X	1
Feldt-Rasmussen, B; Holst, JJ; Hornum, M; Idorn, T; Jørgensen, M; Knop, FK	2
Coester, HV; Forst, T; Hincelin-Méry, A; Kapitza, C; Poitiers, F; Ruus, P	1
Cho, YM; Kim, MY; Kim, S; Lee, JC; Oh, TJ; Park, KS; Shin, JY	1
Chang, J; Greenfield, JR; Horowitz, M; Rayner, CK; Samocha-Bonet, D; Wu, T	1
Blaak, EE; Holst, JJ; Knop, FK; Konings, E; Schrauwen, P; Timmers, S	1
Alssema, M; Dekker, JM; Eekhoff, EM; Gastaldelli, A; Hart, LM; Holst, JJ; Mari, A; Nijpels, G; Rijkelijkhuizen, JM; Scheffer, PG; Teerlink, T	1
Anděl, M; Červinková, Z; Fontana, J	1
Borgoño, CA; Kramer, CK; Retnakaran, R; Van Nostrand, P; Zinman, B	1
Aoki, K; Honda, K; Kamisoyama, H; Nakanishi, K; Saneyasu, T; Shimatani, T; Yamaguchi, T	1
Calanna, S; Di Pino, A; Knop, FK; Piro, S; Purrello, F; Rabuazzo, AM; Scicali, R	1
Aylor, KW; Basu, A; Chai, W; Fowler, DE; Jahn, LA; Liu, Z; Sauder, MA; Subaran, SC	1
Couper, JJ; Horowitz, M; Kritas, S; Martin, AJ; Perano, SJ; Rayner, CK; Sullivan, T	1
Bagger, JI; Hansen, T; Holst, JJ; Knop, FK; Pedersen, O; Vilsbøll, T; Østoft, SH	1
Bound, M; Checklin, H; Horowitz, M; Jones, KL; Lange, K; Marathe, CS; Rayner, CK; Standfield, S; Wishart, J	1
Abroun, S; Allahverdi, A; Jafarian, A; Pourpak, Z; Soleimani, M; Taghikhani, M	1
Holmes, D	1
de Oliveira, Mda S; Geloneze, B; Novaes, FS; Pareja, JC; Tambascia, MA; Vasques, AC	1
Aulinger, BA; D'Alessio, DA; Drazen, DL; Seeley, RJ; Smith, EP; Ulrich-Lai, Y; Vahl, TP; Woods, SC	1
Pellitero, S; Puig-Domingo, M	1
Abdulla, H; Atherton, PJ; Idris, I; Phillips, B; Smith, K; Wilkinson, D	1
Deng, Y; Gu, W; Gu, Y; Hong, J; Liu, T; Ning, G; Shi, J; Sun, Z; Wang, C; Wang, W; Yao, S; Zhang, Y; Zheng, S	1
Abuaysheh, S; Batra, M; Chaudhuri, A; Dandona, P; Dhindsa, S; Ghanim, H; Green, K; Makdissi, A; Patel, R	1
Katsuno, T; Kusunoki, Y; Matsuo, T; Miuchi, M; Miyagawa, J; Murai, K; Namba, M; Ochi, F; Tokuda, M	1
Bambrick, JE; Chia, B; Deane, AM; Debreceni, TL; Horowitz, M; Nguyen, NQ; Rayner, CK; Wishart, J; Young, RL	1
Escalada, FJ	1
Bräuner-Osborne, H; Iversen, H; Knudsen, SM; Nøhr, AC; Roed, SN; Waldhoer, M; Wismann, P	1
Ahrén, B; Deacon, CF; Holst, JJ; Lindgren, O; Pacini, G; Tura, A	1
Deacon, CF; Hamamoto, Y; Hamasaki, A; Harada, N; Hirano, T; Holst, JJ; Inagaki, N; Iwasaki, M; Kuroe, A; Kurose, T; Lee, S; Murotani, K; Seino, Y; Watanabe, K; Yabe, D; Yamane, S	1
Ackermans, MT; de Sonnaville, JJJ; Frier, BM; Hartmann, B; Hoekstra, JBL; Holleman, F; Holst, JJ; Knop, FK; Schopman, JE; Stades, AM; Zwertbroek, R	1
Cho, WK; Jung, MH; Park, MS; Park, SH; Suh, BK	1
Bagger, JI; Hansen, T; Hartmann, B; Holst, JJ; Knop, FK; Pedersen, O; Vilsbøll, T; Østoft, SH	1
Bindels, LB; Burkart, V; Hartmann, B; Henrich, B; Holst, JJ; Hwang, JH; Kolb, H; MacKenzie, C; Martinez, I; Nowotny, B; Nowotny, P; Pacini, G; Roden, M; Schloot, NC; Simon, MC; Stehle, P; Strassburger, K; Walter, J; Zivehe, F	1
Gyldenløve, M; Holst, JJ; Knop, FK; Skov, L; Vilsbøll, T; Zachariae, C	1
Heden, TD; Kanaley, JA; Leidy, HJ; Nyhoff, LM; Park, YM; Thyfault, JP; Winn, NC	1
Craft, D; Warunek, D; Yi, J	1
Deacon, CF; Eelderink, C; Holst, JJ; Koehorst, M; Noort, MW; Oudhuis, L; Poutanen, K; Priebe, MG; Rehfeld, JF; Sozer, N; Vonk, RJ	1
Østoft, SH	1
Ahrén, B; Alsalim, W; Bizzotto, R; Mari, A; Omar, B; Pacini, G; Tura, A	1
Augstein, P; Bandala-Sanchez, E; Campbell, P; Harrison, LC; Hawthorne, WJ; Heinke, P; Kay, TW; Loudovaris, T; Naselli, G; Rogers, K; Thomas, HE	1
Benatti, FB; Harder-Lauridsen, NM; Krogh-Madsen, R; Lyngbæk, MP; Møller, K; Nielsen, ST; Pedersen, BK; Wedell-Neergaard, AS	1
Iwasaki, M; Kurose, T; Kuwata, H; Maeda, H; Minami, K; Murotani, K; Nakada, K; Nosaka, C; Seino, S; Seino, Y; Shimizu, S; Yabe, D	1
Gluud, L; Holst, JJ; Junker, AE; Knop, FK; Vilsbøll, T	1
Chae, KS; Choi, OK; Chung, SS; Ham, DS; Jung, HS; Kim, JW; Kim, MJ; Lee, H; Park, KS; Yoon, KH	1
Borg, M; Bound, MJ; Deacon, CF; Horowitz, M; Jones, KL; Little, TJ; Rayner, CK; Wu, T; Zhang, X	1
Deacon, CF; Eelderink, C; Holst, JJ; Koehorst, M; Noort, MWJ; Oudhuis, L; Poutanen, K; Priebe, MG; Rehfeld, JF; Sozer, N; Vonk, RJ	1
Åsberg, A; Egeland, EJ; Feldt-Rasmussen, B; Halden, TA; Hartmann, A; Holst, JJ; Hornum, M; Jenssen, T; Khiabani, HZ; Knop, FK; Midtvedt, K	1
Beglinger, C; Cajacob, L; Drewe, J; Herzog, R; Meyer-Gerspach, AC; Riva, D; Wölnerhanssen, BK	1
Dincer, F; Farr, OM; Gavrieli, A; Hamnvik, OP; Mantzoros, CS; Sahin-Efe, A; Vamvini, MT	1
Arslanian, S; Bacha, F; Hannon, T; Hughan, KS; Kim, JY; Lee, S; Michaliszyn, SF; Nasr, A; Tfayli, H	1
Cuchel, M; De Leon, DD; Gudipaty, L; Hadjiliadis, D; Kelly, A; Kubrak, C; Malik, S; Nyirjesy, SC; Peleckis, AJ; Rickels, MR; Rosenfeld, NK; Rubenstein, RC; Sheikh, S; Stefanovski, D	1
Jütte, H; Meier, J; Montanya, E; Nauck, M; Schmidt, W; Tannapfel, A; Ueberberg, S; Uhl, W	1
Jiang, G; Liang, G; Song, X; Wang, F; Xu, H; Zhang, L; Zhou, L	1
Gilbert, JD; Goldenberg, RM; Perkins, BA; Verma, S; Zinman, B	1
Bagger, JI	1
Coppieters, K; Hasselby, JP; Kirk, RK; Knudsen, LB; Mortensen, PG; Pedersen, L; Pyke, C; von Herrath, MG	1
Beaudry, JL; Campbell, JE; Cao, X; Drucker, DJ; Flock, GB; Panaro, BL	1
Habener, JF; Stanojevic, V	1
Bozkurt, S; Cira, DK; Ozdem, S; Sari, R; Yilmaz, N	1
Bloom, S; Cegla, J; Creaser, CS; Howard, JW; Jones, B; Kay, RG; Tan, T	1
Junker, AE	1
Anděl, M; Gojda, J; Plíhalová, A; Polák, J; Potočková, J; Straková, R; Tůma, P	1
Holst, JJ; Knop, FK; Pedersen, J; Wewer Albrechtsen, NJ	1
Horowitz, M; Jones, KL; Little, TJ; Rayner, CK; Watson, LE; Wu, T	1
Marks, V	1
Seufert, J	1
Bunzel, M; Cheewatrakoolpong, B; Chobanian, HR; Colletti, SL; Di Salvo, J; Feng, Y; Forrest, G; Howard, AD; Kirkland, ME; Kosinski, DT; Li, X; Mane, J; Miller, C; Miller, MW; Ogawa, AM; Pachanski, MJ; Plummer, CW; Souza, S; Szeto, D; Tatosian, DA; Thomas-Fowlkes, BS; Trujillo, ME; Weinglass, AB; Xue, J	1
Ahlqvist, E; Almgren, P; Asplund, O; Groop, L; Hakaste, L; Holst, JJ; Krus, U; Laurila, E; Lindqvist, A; Melander, O; Nilsson, PM; Orho-Melander, M; Ottosson-Laakso, E; Prasad, RB; Sonestedt, E; Tuomi, T; Wierup, N	1
Chamarthi, B; Chen, L; Florez, JC; Goldfine, A; Hudson, M; Kaur, V; Littleton, KR; Manning, AK; Merino, J; Srinivasan, S; Thomas, MK	1
Bloom, SR; Scott, RV	1
Trautmann, ME; Vora, J	1
Engelbrechtsen, L; Færch, K; Gjesing, AP; Grarup, N; Hansen, T; Holst, JJ; Jonsson, A; Jørgensen, ME; Jørgensen, T; Kanters, JK; Mahendran, Y; Pedersen, O; Torekov, S; Vestergaard, H; Weeke, PE; Witte, DR	1
Berger, C; Friedrich, A; Koepsell, H; Metzger, M; Mühlemann, M; Otto, C; Walles, H; Zdzieblo, D	1
Heinla, I; Jagomäe, T; Koppel, T; Pallase, M; Plaas, M; Seppa, K; Terasmaa, A; Toots, M; Vasar, E	1
D'Aiuto, F; Gennai, S; Graziani, F; Masi, S; Petrini, M; Santini, E; Seghieri, M; Solini, A; Suvan, J	1
Chikh, K; Marchand, L; Thivolet, C	1
D'Alessio, DA; Gastaldelli, A; Salehi, M	1
Alfieri, S; Capece, U; Carfì, A; Cefalo, CMA; Cinti, F; Ferraro, PM; Giaccari, A; Holst, JJ; Impronta, F; Mari, A; Mezza, T; Moffa, S; Pontecorvi, A; Quero, G; Sorice, GP	1
Bhansali, A; Bhansali, S; Bhat, K; Dutta, P; Kochhar, R; Kurpad, AV; Mudaliar, S; Mukherjee, KK; Sachdeva, N; Shekhawat, VS; Sinha, SK; Vaiphei, K	1
Abrahamsson, N; Almby, KE; Eriksson, JW; Hammar, U; Karlsson, FA; Lundqvist, MH; Panagiotou, A; Sundbom, M; Thombare, K; Wiklund, U	1
De Leon, DD; Hadjiliadis, D; Kelly, A; Kilberg, MJ; Kubrak, C; Rickels, MR; Rubenstein, RC; Sheikh, S; Stefanovski, D	1
Brandi, L; Bressendorff, I; Feldt-Rasmussen, B; Hansen, HP; Hartmann, B; Holst, JJ; Hornum, M; Idorn, T; Jørgensen, MB; Knop, FK; Rydahl, C; van Hall, G; Wewer Albrechtsen, NJ	1
Brooks, A; Guyton, J; Jeon, M	1
Abbara, A; Bech, P; Comninos, AN; Coumbe, B; Crustna, Y; Dhillo, WS; Eng, PC; Izzi-Engbeaya, C; Jones, S; Machenahalli, PC; Mills, E; Minnion, J; Modi, M; Pacuszka, E; Panayi, C; Papadopoulou, D; Phylactou, M; Plumptre, I; Ratnasabapathy, R; Starikova, J; Sykes, M; Tan, T; Tharakan, G; Veldhuis, J; Wing, VC; Yang, L	1
Bojsen-Møller, KN; Dirksen, C; Fenger, M; Holst, JJ; Kristiansen, VB; Madsbad, S; Martinussen, C; Svane, MS; van Hall, G; Veedfald, S; Wewer Albrechtsen, NJ	1
Ahrén, B; Pacini, G	1
Ali Mondal, S; Anne M, B; Basu, M; Chakrabarti, P; Das, K; Ghosh, I; Ghosh, S; Mukhopadhyay, P; Nargis, T; Pandit, K	1
Brown, JL; Campbell, JE; Capozzi, ME; Chazotte, BM; Clifford, A; D'Alessio, DA; El, K; Encisco, SE; Gray, SM; Jin, E; Knuth, ER; Merrins, MJ; Nunez, DJ; Sloop, KW; Svendsen, B	1
Broughton, KS; LeMieux, MJ; Rao, M; Zumbro, EL	1
Hoshino, R; Kamiyama, T; Kondo, S; Kosakamoto, H; Matsuoka, R; Nakamura, A; Niwa, R; Obata, F; Tanimoto, H; Yoshinari, Y	1
Del Prato, S; Gallwitz, B; Holst, JJ; Meier, JJ	1
Choi, YK; Jeon, JH; Kwon, OK; Park, JY; Park, KB	1
Mandarim-de-Lacerda, CA; Spezani, R	1
Bando, S; Fujimoto, K; Ichikawa, R; Miyatsuka, T; Motomiya, T; Shichiri, M; Taguchi, M; Taguchi, T; Takano, K	1
Chepurny, OG; Collier, JJ; Cooney, RN; Holz, GG; Leech, CA; Meng, Q; Molnar, ME; Pruekprasert, N	1
Barbot, M; Basso, D; Ceccato, F; Giordano, C; Guarnotta, V; Mondin, A; Regazzo, D; Scaroni, C	1
D'Alessio, DA; De Leon, DD; Doliba, A; Eiel, JN; Flatt, AJ; Gallagher, K; Gallop, R; Hadjiliadis, D; Kelly, A; Nyirjesy, SC; Peleckis, AJ; Rickels, MR; Rubenstein, RC; Sheikh, S; Stefanovski, D; Tami, A	1
Brown, T; Carlson, OD; Clark, JM; Egan, JM; Langan, S; Lee, CJ; Schweitzer, M	1
Forman, JL; Holst, JJ; Hædersdal, S; Knop, FK; Lund, A; Maagensen, H; Nielsen-Hannerup, E; Vilsbøll, T	1
Biancolin, AD; Brubaker, PL; Jeong, H; Martchenko, A; Srikrishnaraj, A	1
Aguilar-Ballester, M; González-Navarro, H; Hurtado-Genovés, G; Jiménez-Martí, E; Martínez-Hervás, S	1
Fridh, MK; Gerbek, T; Hartmann, B; Holst, JJ; Mathiesen, S; Müller, K; Nissen, AA; Soerum, ME; Sørensen, K; Vadmand, AC	1
Artoni, RF; Caproni, P; Cleva, R; Estabile, PC; Kuga, R; Milléo, FQ; Mota, FC; Moura, EGH; Santo, MA	1
Javeed, N; Sen, S	1
Rehfeld, JF	1
Gallwitz, B	1
Csanalosi, M; Kabisch, S; Kemper, M; Keyhani-Nejad, F; Markova, M; Meyer, NMT; Pfeiffer, AFH; Pivovarova-Ramich, O; Rohn, S; Schäfer, SM; Schuppelius, B; Zhang, J	1
Babu, S; Gowshika, K; Kumar, NP; Lakshan Raj, S; Mittal, R; Pandiarajan, AN; Putlibai, S; Rajamanickam, A; Ramanan, PV; Sasidaran, R; Selvaraj, N; Venkataraman, A	1
Barber, TM; Hanson, P; Kyrou, I; Pelling, M; Randeva, H; Statham, L	1
Gasbjerg, LS; Holst, JJ; Knop, FK; Meier, JJ; Rosenkilde, MM	1
Andrews, RC; Bowman, P; Flanagan, SE; Hammersley, S; Hartmann, B; Hattersley, AT; Holst, JJ; Knight, BA; Leveridge, M; McDonald, TJ; Patel, KA; Shepherd, MH; Shields, BM; Spaull, SR	1
D'Alessio, DA; Marks, V	1

Reviews

32 review(s) available for glucagon and incretins

Article	Year
Dipeptidyl peptidase IV inhibitors and diabetes therapy. Frontiers in bioscience : a journal and virtual library, 2008, Jan-01, Volume: 13 Topics: Animals; Diabetes Mellitus; Dipeptidyl-Peptidase IV Inhibitors; Enzyme Inhibitors; Glucagon; Glucose; Homeostasis; Humans; Incretins; Insulin; Insulin Resistance; Models, Biological	2008
[New therapies for type 2 diabetes: what place for incretin-based agents and rimonabant compared to the previous ones?]. La Revue de medecine interne, 2008, Volume: 29, Issue:11 Topics: Administration, Oral; Diabetes Mellitus, Type 2; Glucagon; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemic Agents; Incretins; Metabolic Syndrome; Metformin; Piperidines; Pyrazoles; Rimonabant; Safety; Sulfonylurea Compounds; Thiazolidinediones	2008
An overview of incretin hormones. The Journal of family practice, 2008, Volume: 57, Issue:9 Suppl Topics: Blood Glucose; Diabetes Mellitus, Type 2; Glucagon; Humans; Incretins; Insulin Resistance; Insulin-Secreting Cells	2008
The incretins: from the concept to their use in the treatment of type 2 diabetes. Part A: incretins: concept and physiological functions. Diabetes & metabolism, 2008, Volume: 34, Issue:6 Pt 1 Topics: Adipose Tissue; Body Weight; Diabetes Mellitus, Type 2; Gastric Emptying; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Incretins; Insulin; Insulin Secretion; Overweight; Receptors, Glucagon	2008
Exenatide: a review from pharmacology to clinical practice. Diabetes, obesity & metabolism, 2009, Volume: 11, Issue:6 Topics: Blood Glucose; Body Weight; C-Reactive Protein; Diabetes Mellitus, Type 2; Exenatide; Fasting; Female; Glucagon; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Incretins; Insulin; Male; Peptides; Randomized Controlled Trials as Topic; Venoms; Weight Loss	2009
Current and emerging therapies: an overview of incretin-based therapy in the management of type 2 diabetes. Journal of the American Academy of Nurse Practitioners, 2008, Volume: 20 Suppl 1 Topics: Administration, Oral; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Disease Progression; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Incretins; Insulin Resistance; Middle Aged; Nurse Practitioners; Patient Selection; Primary Health Care	2008
Incretin physiology and its role in type 2 diabetes mellitus. The Journal of the American Osteopathic Association, 2010, Volume: 110, Issue:7 Suppl 7 Topics: Adamantane; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Glucagon; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Incretins; Insulin; Liraglutide; Peptides; Pyrazines; Sitagliptin Phosphate; Triazoles; Venoms	2010
Incretin-based therapies in the management of type 2 diabetes: rationale and reality in a managed care setting. The American journal of managed care, 2010, Volume: 16, Issue:7 Suppl Topics: Adamantane; Algorithms; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Evidence-Based Medicine; Exenatide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Incretins; Insulin; Insulin Secretion; Liraglutide; Managed Care Programs; Peptides; Pyrazines; Receptors, Glucagon; Sitagliptin Phosphate; Triazoles; Venoms	2010
New physiological effects of the incretin hormones GLP-1 and GIP. Danish medical bulletin, 2011, Volume: 58, Issue:2 Topics: Adult; Appetite; Eating; Gastric Emptying; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Incretins; Islet Amyloid Polypeptide; Male; Postprandial Period	2011
Is the GLP-1 system a viable therapeutic target for weight reduction? Reviews in endocrine & metabolic disorders, 2011, Volume: 12, Issue:3 Topics: Animals; Body Weight; Glucagon; Glucagon-Like Peptide 1; Humans; Incretins; Insulin; Weight Loss	2011
Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet (London, England), 2011, Jul-09, Volume: 378, Issue:9786 Topics: Adipose Tissue; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Diabetes, Gestational; Diabetic Retinopathy; Epigenesis, Genetic; Female; Fetal Development; Genetic Predisposition to Disease; Glucagon; Glucagon-Like Peptide 1; Homeostasis; Humans; Incretins; Insulin Resistance; Insulin-Secreting Cells; Life Style; Liver; Muscle, Skeletal; Myocardium; Obesity; Prediabetic State; Pregnancy	2011
Incretin hormones and the expanding families of glucagon-like sequences and their receptors. Diabetes, obesity & metabolism, 2011, Volume: 13 Suppl 1 Topics: Animals; Base Sequence; Chickens; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptides; Humans; Incretins; Mammals; Phylogeny; Protein Precursors; Receptors, Glucagon; Xenopus	2011
Regulation of glucagon secretion by incretins. Diabetes, obesity & metabolism, 2011, Volume: 13 Suppl 1 Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Incretins; Rats; Receptors, Glucagon	2011
Insulin sensitivity and secretion modifications after bariatric surgery. Journal of endocrinological investigation, 2012, Volume: 35, Issue:7 Topics: Animals; Bariatric Surgery; Body Mass Index; Diabetes Mellitus, Type 2; Gastric Mucosa; Ghrelin; Glucagon; Glucagon-Like Peptide 1; Glucagon-Secreting Cells; Humans; Incretins; Insulin Resistance; Insulin-Secreting Cells; Intestinal Mucosa; Obesity, Morbid	2012
[Effects of GLP-1 (glucagon-like peptide 1) on liver]. Vnitrni lekarstvi, 2013, Volume: 59, Issue:7 Topics: Animals; Glucagon; Glucagon-Like Peptide 1; Hepatocytes; Humans; Hypoglycemic Agents; Incretins; Insulin; Lipid Metabolism; Liver Diseases; Non-alcoholic Fatty Liver Disease; Oxidative Stress	2013
[New therapies for type 2 diabetes mellitus]. Medicina clinica, 2015, Jun-22, Volume: 144, Issue:12 Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Anti-Obesity Agents; Diabetes Mellitus, Type 2; Diacylglycerol O-Acyltransferase; Dipeptidyl Peptidase 4; Drug Therapy, Combination; Drugs, Investigational; Enzyme Inhibitors; Glucagon; Glucagon-Like Peptide-1 Receptor; Glucokinase; Gluconeogenesis; Glucose; Humans; Hypoglycemic Agents; Incretins; Insulin Resistance; Insulin, Long-Acting; Molecular Targeted Therapy; Obesity; Phosphofructokinase-2; Sodium-Glucose Transport Proteins; Weight Loss	2015
Physiological mechanisms of action of incretin and insulin in regulating skeletal muscle metabolism. Current diabetes reviews, 2014, Volume: 10, Issue:5 Topics: Blood Flow Velocity; Blood Glucose; Diabetes Mellitus, Type 2; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Homeostasis; Humans; Hyperglycemia; Hypoglycemic Agents; Incretins; Insulin; Insulin Resistance; Microcirculation; Muscle, Skeletal	2014
Can the Combination of Incretin Agents and Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors Reconcile the Yin and Yang of Glucagon? Canadian journal of diabetes, 2017, Volume: 41, Issue:1 Topics: Animals; Benzhydryl Compounds; Diabetes Mellitus; Drug Therapy, Combination; Glucagon; Glucosides; Humans; Hypoglycemic Agents; Incretins; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors	2017
Physiological and pathophysiological aspects of incretin hormones and glucagon. Danish medical journal, 2017, Volume: 64, Issue:1 Topics: Animals; Appetite; Diabetes Mellitus, Type 2; Enteroendocrine Cells; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Incretins; Insulin; Oxyntomodulin; Peptide Fragments	2017
The role of incretin hormones and glucagon in patients with liver disease. Danish medical journal, 2017, Volume: 64, Issue:5 Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose Intolerance; Humans; Incretins; Insulin; Liver; Mice; Non-alcoholic Fatty Liver Disease	2017
The Gut: A Key to the Pathogenesis of Type 2 Diabetes? Metabolic syndrome and related disorders, 2017, Volume: 15, Issue:6 Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Gastric Emptying; Gastrointestinal Tract; Glucagon; Humans; Incretins; Insulin; Insulin Secretion; Insulin-Secreting Cells; Intestines; Postprandial Period	2017
Genetic determinants of circulating GIP and GLP-1 concentrations. JCI insight, 2017, 11-02, Volume: 2, Issue:21 Topics: ABO Blood-Group System; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Enteroendocrine Cells; Female; Gastric Inhibitory Polypeptide; Gastrointestinal Hormones; Gastrointestinal Tract; Genetic Variation; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-2 Receptor; Glucose; Glucose Tolerance Test; Homeodomain Proteins; Humans; Incretins; Insulin; Insulin-Secreting Cells; Islets of Langerhans; Male; Middle Aged; Prospective Studies; Receptors, Gastrointestinal Hormone; RNA, Messenger; Sodium-Glucose Transporter 1	2017
Problem or solution: The strange story of glucagon. Peptides, 2018, Volume: 100 Topics: Diabetes Mellitus, Type 2; Energy Metabolism; Glucagon; Humans; Hyperglycemia; Incretins; Insulin; Obesity; Receptors, Glucagon	2018
Use of glucagon-like peptide-1 receptor agonists among individuals on basal insulin requiring treatment intensification. Diabetic medicine : a journal of the British Diabetic Association, 2018, Volume: 35, Issue:6 Topics: Administration, Oral; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glucagon; Glucagon-Like Peptide-1 Receptor; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Incretins; Insulin Glargine; Insulin, Long-Acting; Peptides; Postprandial Period; Treatment Outcome	2018
Glucagon-like peptide 1 receptor agonists in type 1 diabetes mellitus. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2019, Oct-15, Volume: 76, Issue:21 Topics: Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Exenatide; Glucagon; Glucagon-Like Peptide-1 Receptor; Glucagon-Secreting Cells; Humans; Hypoglycemia; Hypoglycemic Agents; Incretins; Insulin; Liraglutide; Treatment Outcome; Weight Loss	2019
Glucose effectiveness: Lessons from studies on insulin-independent glucose clearance in mice. Journal of diabetes investigation, 2021, Volume: 12, Issue:5 Topics: Administration, Intravenous; Adult; Aged; Animals; Biological Transport; Diabetes Mellitus, Type 2; Disease Models, Animal; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Homeostasis; Humans; Incretins; Insulin; Insulin Resistance; Insulin Secretion; Male; Mice; Middle Aged	2021
The incretin/glucagon system as a target for pharmacotherapy of obesity. Obesity reviews : an official journal of the International Association for the Study of Obesity, 2022, Volume: 23, Issue:2 Topics: Animals; Diabetes Mellitus, Type 2; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide-1 Receptor; Humans; Incretins; Obesity	2022
The current significance and prospects for the use of dual receptor agonism GLP-1/Glucagon. Life sciences, 2022, Jan-01, Volume: 288 Topics: Animals; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Incretins; Obesity	2022
Novel Therapies for Cardiometabolic Disease: Recent Findings in Studies with Hormone Peptide-Derived G Protein Coupled Receptor Agonists. Nutrients, 2022, Sep-13, Volume: 14, Issue:18 Topics: Animals; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose; Incretins; Peptides; Proglucagon	2022
Four sidenotes about glucagon peptides. Peptides, 2023, Volume: 159 Topics: Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptide 1; Incretins; Peptides	2023
[Gastrointestinal hormones: their increasing pharmacotherapeutic relevance in metabolic diseases]. Innere Medizin (Heidelberg, Germany), 2023, Volume: 64, Issue:2 Topics: Diabetes Mellitus, Type 2; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptide 1; Humans; Incretins	2023
The importance of glucose-dependent insulinotropic polypeptide receptor activation for the effects of tirzepatide. Diabetes, obesity & metabolism, 2023, Volume: 25, Issue:11 Topics: Blood Glucose; Diabetes Mellitus, Type 2; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Incretins	2023

Trials

38 trial(s) available for glucagon and incretins

Article	Year
The effect of exogenous glucagon-like peptide-1 on the glycaemic response to small intestinal nutrient in the critically ill: a randomised double-blind placebo-controlled cross over study. Critical care (London, England), 2009, Volume: 13, Issue:3 Topics: Adult; Aged; Area Under Curve; Blood Glucose; Critical Illness; Cross-Over Studies; Double-Blind Method; Enteral Nutrition; Female; Glucagon; Glucagon-Like Peptide 1; Humans; Hyperglycemia; Hypoglycemia; Incretins; Infusions, Intravenous; Insulin; Male; Middle Aged	2009
Acute effects of casein on postprandial lipemia and incretin responses in type 2 diabetic subjects. Nutrition, metabolism, and cardiovascular diseases : NMCD, 2010, Volume: 20, Issue:2 Topics: Aged; Biomarkers; Blood Glucose; Caseins; Chylomicrons; Cross-Over Studies; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Dietary Fats; Dietary Proteins; Diterpenes; Female; Glucagon; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hyperlipidemias; Hypoglycemic Agents; Incretins; Insulin; Male; Middle Aged; Postprandial Period; Retinyl Esters; Time Factors; Triglycerides; Vitamin A	2010
Orally administered glucagon-like peptide-1 affects glucose homeostasis following an oral glucose tolerance test in healthy male subjects. Clinical pharmacology and therapeutics, 2009, Volume: 86, Issue:6 Topics: Administration, Oral; Adult; Appetite; Blood Glucose; Caprylates; Cross-Over Studies; Double-Blind Method; Drug Carriers; Gastric Emptying; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Homeostasis; Human Growth Hormone; Humans; Incretins; Insulin; Intestinal Absorption; Male; Peptide Fragments; Postprandial Period; Reference Values; Young Adult	2009
Differential incretin effects of GIP and GLP-1 on gastric emptying, appetite, and insulin-glucose homeostasis. Neurogastroenterology and motility, 2010, Volume: 22, Issue:11 Topics: Adult; Appetite; Blood Glucose; C-Peptide; Cross-Over Studies; Double-Blind Method; Female; Gastric Emptying; Gastric Inhibitory Polypeptide; Ghrelin; Glucagon; Glucagon-Like Peptide 1; Homeostasis; Humans; Hunger; Immunoassay; Incretins; Insulin; Male; Peptide YY; Satiety Response	2010
Gastric emptying, incretin hormone secretion, and postprandial glycemia in cystic fibrosis--effects of pancreatic enzyme supplementation. The Journal of clinical endocrinology and metabolism, 2011, Volume: 96, Issue:5 Topics: Adult; Blood Glucose; Cystic Fibrosis; Dietary Carbohydrates; Dietary Fats; Double-Blind Method; Female; Gastric Emptying; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Hyperglycemia; Incretins; Insulin; Lipase; Male; Pancreas; Young Adult	2011
Impaired incretin-induced amplification of insulin secretion after glucose homeostatic dysregulation in healthy subjects. The Journal of clinical endocrinology and metabolism, 2012, Volume: 97, Issue:4 Topics: Adult; Blood Glucose; C-Peptide; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Clamp Technique; Glucose Intolerance; Glucose Tolerance Test; Humans; Incretins; Infusions, Intravenous; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Kinetics; Male; Severity of Illness Index; Young Adult	2012
The role of endogenous incretin secretion as amplifier of glucose-stimulated insulin secretion in healthy subjects and patients with type 2 diabetes. Diabetes, 2012, Volume: 61, Issue:9 Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide-1 Receptor; Glucose; Glucose Clamp Technique; Humans; Incretins; Insulin; Insulin Secretion; Male; Middle Aged; Peptide Fragments; Receptors, Glucagon	2012
Islet-cell dysfunction induced by glucocorticoid treatment: potential role for altered sympathovagal balance? Metabolism: clinical and experimental, 2013, Volume: 62, Issue:4 Topics: Adolescent; Adult; Anthropometry; Arginine; Blood Glucose; Dose-Response Relationship, Drug; Double-Blind Method; Glucagon; Glucocorticoids; Glucose Clamp Technique; Heart Rate; Humans; Hyperglycemia; Incretins; Islets of Langerhans; Male; Pancreatic Diseases; Pancreatic Function Tests; Prednisolone; Stimulation, Chemical; Sympathetic Nervous System; Vagus Nerve; Young Adult	2013
Mosapride citrate, a 5-HT₄ receptor agonist, increased the plasma active and total glucagon-like peptide-1 levels in non-diabetic men. Endocrine journal, 2013, Volume: 60, Issue:4 Topics: Adult; Benzamides; Blood Glucose; Gastric Inhibitory Polypeptide; Gastrointestinal Agents; Gastrointestinal Tract; Glucagon; Glucagon-Like Peptide 1; Glucose Intolerance; Humans; Hypoglycemia; Hypoglycemic Agents; Incretins; Insulin; Male; Morpholines; Postprandial Period; Serotonin 5-HT4 Receptor Agonists; Up-Regulation	2013
Pharmacodynamic characteristics of lixisenatide once daily versus liraglutide once daily in patients with type 2 diabetes insufficiently controlled on metformin. Diabetes, obesity & metabolism, 2013, Volume: 15, Issue:7 Topics: Adult; Aged; C-Peptide; Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Resistance; Female; Glucagon; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hyperglycemia; Hyperinsulinism; Hypoglycemic Agents; Incretins; Injections, Subcutaneous; Liraglutide; Male; Metformin; Middle Aged; Peptides	2013
Effects of intraduodenal glutamine on incretin hormone and insulin release, the glycemic response to an intraduodenal glucose infusion, and antropyloroduodenal motility in health and type 2 diabetes. Diabetes care, 2013, Volume: 36, Issue:8 Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Duodenum; Female; Gastric Emptying; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Glutamine; Healthy Volunteers; Humans; Incretins; Insulin; Insulin Secretion; Male	2013
Thirty days of resveratrol supplementation does not affect postprandial incretin hormone responses, but suppresses postprandial glucagon in obese subjects. Diabetic medicine : a journal of the British Diabetic Association, 2013, Volume: 30, Issue:10 Topics: Antioxidants; Blood Glucose; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Fasting; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Incretins; Male; Middle Aged; Obesity; Postprandial Period; Resveratrol; Stilbenes; Time Factors; Treatment Outcome	2013
Pancreatic enzyme supplementation improves the incretin hormone response and attenuates postprandial glycemia in adolescents with cystic fibrosis: a randomized crossover trial. The Journal of clinical endocrinology and metabolism, 2014, Volume: 99, Issue:7 Topics: Adolescent; Blood Glucose; Child; Cross-Over Studies; Cystic Fibrosis; Enzyme Replacement Therapy; Female; Gastric Emptying; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Incretins; Insulin; Male; Pancrelipase; Postprandial Period	2014
Impaired incretin secretion and pancreatic dysfunction with older age and diabetes. Metabolism: clinical and experimental, 2014, Volume: 63, Issue:7 Topics: Adiponectin; Adipose Tissue; Adult; Aged; Aging; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Down-Regulation; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Incretins; Insulin; Insulin Resistance; Insulin Secretion; Male; Middle Aged; Pancreas; Postprandial Period; Up-Regulation	2014
Postprandial glucose, insulin and incretin responses to different carbohydrate tolerance tests. Journal of diabetes, 2015, Volume: 7, Issue:6 Topics: Adolescent; Adult; Aged; Biomarkers; Blood Glucose; C-Peptide; China; Cross-Over Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Female; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Humans; Incretins; Insulin; Male; Middle Aged; Postprandial Period; Predictive Value of Tests; Time Factors; Young Adult	2015
Decreased insulin secretion and incretin concentrations and increased glucagon concentrations after a high-fat meal when compared with a high-fruit and -fiber meal. American journal of physiology. Endocrinology and metabolism, 2015, Feb-01, Volume: 308, Issue:3 Topics: Adult; Diet, High-Fat; Dietary Fats; Dietary Fiber; Down-Regulation; Female; Fruit; Glucagon; Humans; Incretins; Insulin; Insulin Secretion; Male; Meals; Middle Aged; Up-Regulation; Young Adult	2015
Very short-term effects of the dipeptidyl peptidase-4 inhibitor sitagliptin on the secretion of insulin, glucagon, and incretin hormones in Japanese patients with type 2 diabetes mellitus: analysis of meal tolerance test data. Drugs in R&D, 2014, Volume: 14, Issue:4 Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Food; Glucagon; Glucagon-Like Peptide 1; Humans; Incretins; Insulin; Insulin Secretion; Male; Middle Aged; Postprandial Period; Sitagliptin Phosphate	2014
Accelerated intestinal glucose absorption in morbidly obese humans: relationship to glucose transporters, incretin hormones, and glycemia. The Journal of clinical endocrinology and metabolism, 2015, Volume: 100, Issue:3 Topics: 3-O-Methylglucose; Adult; Blood Glucose; Female; Gastric Inhibitory Polypeptide; Gene Expression; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Transport Proteins, Facilitative; Humans; Incretins; Insulin; Intestinal Absorption; Male; Middle Aged; Obesity, Morbid; Time Factors	2015
Incretin effect after oral amino acid ingestion in humans. The Journal of clinical endocrinology and metabolism, 2015, Volume: 100, Issue:3 Topics: Administration, Oral; Adult; Amino Acids; Blood Glucose; C-Peptide; Eating; Electrolytes; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Incretins; Insulin; Insulin Secretion; Male; Solutions; Young Adult	2015
Early phase glucagon and insulin secretory abnormalities, but not incretin secretion, are similarly responsible for hyperglycemia after ingestion of nutrients. Journal of diabetes and its complications, 2015, Volume: 29, Issue:3 Topics: Adult; Aged; Blood Glucose; Eating; Female; Food; Glucagon; Glucose Tolerance Test; Humans; Hyperglycemia; Incretins; Insulin; Insulin Secretion; Male; Middle Aged; Postprandial Period; Time Factors; Young Adult	2015
Effects of sitagliptin on counter-regulatory and incretin hormones during acute hypoglycaemia in patients with type 1 diabetes: a randomized double-blind placebo-controlled crossover study. Diabetes, obesity & metabolism, 2015, Volume: 17, Issue:6 Topics: Adolescent; Adult; Cross-Over Studies; Diabetes Mellitus, Type 1; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Growth Hormone; Humans; Hypoglycemia; Incretins; Male; Middle Aged; Sitagliptin Phosphate; Young Adult	2015
Postprandial incretin and islet hormone responses and dipeptidyl-peptidase 4 enzymatic activity in patients with maturity onset diabetes of the young. European journal of endocrinology, 2015, Volume: 173, Issue:2 Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Fasting; Female; Glucagon; Glucagon-Like Peptide 1; Humans; Incretins; Insulin; Male; Middle Aged; Postprandial Period	2015
Intake of Lactobacillus reuteri improves incretin and insulin secretion in glucose-tolerant humans: a proof of concept. Diabetes care, 2015, Volume: 38, Issue:10 Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Glucose; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Incretins; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Limosilactobacillus reuteri; Male; Middle Aged; Obesity; Oxidative Stress; Pilot Projects; Probiotics; Prospective Studies; Protein Precursors	2015
Prior exercise does not alter the incretin response to a subsequent meal in obese women. Peptides, 2015, Volume: 71 Topics: Adult; Blood Glucose; Eating; Exercise; Female; Glucagon; Humans; Incretins; Obesity	2015
The structure of wheat bread influences the postprandial metabolic response in healthy men. Food & function, 2015, Volume: 6, Issue:10 Topics: Bile Acids and Salts; Blood Glucose; Body Mass Index; Bread; Breath Tests; Carbon Dioxide; Cross-Over Studies; Gastric Inhibitory Polypeptide; Glucagon; Humans; Incretins; Insulin; Insulin Resistance; Male; Portion Size; Postprandial Period; Triticum; Young Adult	2015
Incretin hormones and maturity onset diabetes of the young--pathophysiological implications and anti-diabetic treatment potential. Danish medical journal, 2015, Volume: 62, Issue:9 Topics: Academic Dissertations as Topic; Adult; Blood Glucose; Cross-Over Studies; Denmark; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Double-Blind Method; Female; Glucagon; Glucagon-Like Peptide-1 Receptor; Glucose; Humans; Hypoglycemia; Hypoglycemic Agents; Incretins; Islets of Langerhans; Male; Postprandial Period	2015
Meal sequence and glucose excursion, gastric emptying and incretin secretion in type 2 diabetes: a randomised, controlled crossover, exploratory trial. Diabetologia, 2016, Volume: 59, Issue:3 Topics: Adult; Aged; C-Peptide; Cross-Over Studies; Diabetes Mellitus, Type 2; Diet; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Incretins; Insulin; Japan; Male; Meals; Middle Aged; Postprandial Period	2016
Diabetic and nondiabetic patients with nonalcoholic fatty liver disease have an impaired incretin effect and fasting hyperglucagonaemia. Journal of internal medicine, 2016, Volume: 279, Issue:5 Topics: Adult; Blood Glucose; C-Reactive Protein; Diabetes Mellitus, Type 2; Fasting; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Intolerance; Humans; Incretins; Insulin; Male; Middle Aged; Non-alcoholic Fatty Liver Disease	2016
A Protein Preload Enhances the Glucose-Lowering Efficacy of Vildagliptin in Type 2 Diabetes. Diabetes care, 2016, Volume: 39, Issue:4 Topics: Adamantane; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Gastric Emptying; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Incretins; Insulin; Male; Metformin; Middle Aged; Nitriles; Postprandial Period; Pyrrolidines; Vildagliptin; Whey Proteins	2016
Difference in postprandial GLP-1 response despite similar glucose kinetics after consumption of wheat breads with different particle size in healthy men. European journal of nutrition, 2017, Volume: 56, Issue:3 Topics: Appetite; Bile Acids and Salts; Blood Glucose; Body Mass Index; Bread; Cross-Over Studies; Dietary Fiber; Flour; Glucagon; Glucagon-Like Peptide 1; Humans; Incretins; Insulin; Male; Particle Size; Postprandial Period; Triticum; Young Adult	2017
GLP-1 Restores Altered Insulin and Glucagon Secretion in Posttransplantation Diabetes. Diabetes care, 2016, Volume: 39, Issue:4 Topics: Adult; Aged; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Female; Glucagon; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Incretins; Infusions, Intravenous; Insulin; Insulin Secretion; Kidney Transplantation; Male; Middle Aged; Proinsulin	2016
Mechanisms Regulating Insulin Response to Intragastric Glucose in Lean and Non-Diabetic Obese Subjects: A Randomized, Double-Blind, Parallel-Group Trial. PloS one, 2016, Volume: 11, Issue:3 Topics: Adult; Blood Glucose; Body Mass Index; Body Weight; C-Peptide; Case-Control Studies; Diabetes Mellitus; Double-Blind Method; Female; Gastric Emptying; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Incretins; Insulin; Insulin Resistance; Male; Middle Aged; Obesity; Young Adult	2016
Effects of GLP-1 on counter-regulatory responses during hypoglycemia after GBP surgery. European journal of endocrinology, 2019, Volume: 181, Issue:2 Topics: Adult; Blood Glucose; Catecholamines; Cross-Over Studies; Exenatide; Female; Gastric Bypass; Glucagon; Glucagon-Like Peptide 1; Glucose Clamp Technique; Heart Rate; Human Growth Hormone; Humans; Hydrocortisone; Hypoglycemia; Incretins; Male; Middle Aged; Parasympathetic Nervous System; Postoperative Period; Sympathetic Nervous System	2019
Effect of the Incretin Hormones on the Endocrine Pancreas in End-Stage Renal Disease. The Journal of clinical endocrinology and metabolism, 2020, 01-01, Volume: 105, Issue:1 Topics: Adult; Denmark; Double-Blind Method; Female; Glucagon; Glucagon-Like Peptide 1; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Incretins; Insulin; Insulin Secretion; Islets of Langerhans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis	2020
Effects of Glucagon-like Peptide-1 on the Reproductive Axis in Healthy Men. The Journal of clinical endocrinology and metabolism, 2020, 04-01, Volume: 105, Issue:4 Topics: Adult; Biomarkers; Cross-Over Studies; Follow-Up Studies; Glucagon; Glucagon-Like Peptide 1; Humans; Incretins; Insulin Secretion; Male; Prognosis; Reproduction; Single-Blind Method; Young Adult	2020
The effect of acute dual SGLT1/SGLT2 inhibition on incretin release and glucose metabolism after gastric bypass surgery. American journal of physiology. Endocrinology and metabolism, 2020, 06-01, Volume: 318, Issue:6 Topics: Blood Glucose; C-Peptide; Canagliflozin; Cross-Over Studies; Gastric Bypass; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Humans; Incretins; Insulin; Middle Aged; Pancreatic Polypeptide; Sodium-Glucose Transporter 1; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors	2020
Effects of GLP-1 and GIP on Islet Function in Glucose-Intolerant, Pancreatic-Insufficient Cystic Fibrosis. Diabetes, 2022, 10-01, Volume: 71, Issue:10 Topics: Adult; Arginine; Blood Glucose; Cystic Fibrosis; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Incretins; Insulin; Proinsulin	2022
The glucagon receptor antagonist LY2409021 does not affect gastrointestinal-mediated glucose disposal or the incretin effect in individuals with and without type 2 diabetes. European journal of endocrinology, 2022, Oct-01, Volume: 187, Issue:4 Topics: Biphenyl Compounds; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 2; Glucagon; Glucose; Humans; Incretins; Insulin; Receptors, Glucagon	2022

Other Studies

94 other study(ies) available for glucagon and incretins

Article	Year
The insulinotropic effect of GIP is impaired in patients with chronic pancreatitis and secondary diabetes mellitus as compared to patients with chronic pancreatitis and normal glucose tolerance. Regulatory peptides, 2007, Dec-04, Volume: 144, Issue:1-3 Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Humans; Incretins; Insulin; Male; Middle Aged; Pancreatitis, Chronic	2007
GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet. American journal of physiology. Endocrinology and metabolism, 2007, Volume: 293, Issue:6 Topics: Adipokines; Adipose Tissue; Animals; Anti-Obesity Agents; Blood Glucose; Body Weight; Corticosterone; Dietary Fats; Eating; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Intolerance; Incretins; Insulin; Insulin Resistance; Lipids; Liver; Male; Mice; Motor Activity; Muscle, Skeletal; Obesity; Pancreas; Receptors, Gastrointestinal Hormone	2007
Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. The Journal of clinical endocrinology and metabolism, 2007, Volume: 92, Issue:12 Topics: Adult; Aged; Blood Glucose; Body Mass Index; C-Peptide; Eating; Female; Food; Gastric Bypass; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Hypoglycemia; Incretins; Insulin; Insulin Resistance; Male; Middle Aged; Obesity; Obesity, Morbid; Postoperative Complications	2007
Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance. Diabetes, 2008, Volume: 57, Issue:3 Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Intolerance; Glucose Tolerance Test; Humans; Incretins; Male; Middle Aged; Triglycerides	2008
Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. The Journal of clinical endocrinology and metabolism, 2008, Volume: 93, Issue:7 Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Diet, Reducing; Female; Gastric Bypass; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Incretins; Male; Middle Aged; Obesity; Weight Loss	2008
Incretin and islet hormonal responses to fat and protein ingestion in healthy men. American journal of physiology. Endocrinology and metabolism, 2008, Volume: 295, Issue:4 Topics: Adult; Blood Glucose; Body Water; Diet; Dietary Fats; Dietary Proteins; Dipeptidyl Peptidase 4; Fatty Acids, Nonesterified; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Incretins; Insulin; Islets of Langerhans; Male; Pancreatic Hormones; Triglycerides	2008
Differential islet and incretin hormone responses in morning versus afternoon after standardized meal in healthy men. The Journal of clinical endocrinology and metabolism, 2009, Volume: 94, Issue:8 Topics: Adult; Blood Glucose; C-Peptide; Fatty Acids, Nonesterified; Gastric Inhibitory Polypeptide; Glucagon; Humans; Incretins; Insulin; Islets of Langerhans; Male; Postprandial Period; Time Factors	2009
Incretins in the ICU: is insulin on its way out? Critical care (London, England), 2009, Volume: 13, Issue:4 Topics: Female; Glucagon; Glucagon-Like Peptide 1; Homeostasis; Humans; Hyperglycemia; Hypoglycemia; Incretins; Insulin; Intensive Care Units; Male; Outcome Assessment, Health Care	2009
Mechanism of action of inhibitors of dipeptidyl-peptidase-4 (DPP-4). Best practice & research. Clinical endocrinology & metabolism, 2009, Volume: 23, Issue:4 Topics: Adamantane; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Glucagon; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Incretins; Insulin; Nitriles; Pyrazines; Pyrrolidines; Sitagliptin Phosphate; Triazoles; Vildagliptin	2009
Postprandial diabetic glucose tolerance is normalized by gastric bypass feeding as opposed to gastric feeding and is associated with exaggerated GLP-1 secretion: a case report. Diabetes care, 2010, Volume: 33, Issue:2 Topics: Area Under Curve; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Enteral Nutrition; Fatty Acids, Nonesterified; Gastric Bypass; Glucagon; Glucagon-Like Peptide 1; Humans; Incretins; Male; Middle Aged; Obesity, Morbid; Peptide YY; Postoperative Period; Postprandial Period	2010
The time has come for incretins, a long time coming. Journal of molecular medicine (Berlin, Germany), 2010, Volume: 88, Issue:4 Topics: Animals; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Glucagon; Humans; Incretins; Mice; Models, Biological; Pancreas	2010
Does glucagon-like peptide-1 receptor agonist therapy add value in the treatment of type 2 diabetes? Focus on exenatide. Diabetes research and clinical practice, 2009, Volume: 86 Suppl 1 Topics: Diabetes Mellitus, Type 2; Exenatide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Incretins; Insulin-Secreting Cells; Peptides; Phenotype; Receptors, Glucagon; Venoms	2009
Reduced glucose tolerance and insulin resistance induced by steroid treatment, relative physical inactivity, and high-calorie diet impairs the incretin effect in healthy subjects. The Journal of clinical endocrinology and metabolism, 2010, Volume: 95, Issue:7 Topics: Adult; Area Under Curve; Blood Glucose; Body Weight; C-Peptide; Diet; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Humans; Incretins; Insulin; Insulin Resistance; Male; Motor Activity; Prednisolone	2010
Impact of exogenous hyperglucagonemia on postprandial concentrations of gastric inhibitory polypeptide and glucagon-like peptide-1 in humans. The Journal of clinical endocrinology and metabolism, 2010, Volume: 95, Issue:8 Topics: Aged; Analysis of Variance; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Incretins; Insulin; Male; Middle Aged; Postprandial Period	2010
Effects of physiological hyperglycemia on duodenal motility and flow events, glucose absorption, and incretin secretion in healthy humans. The Journal of clinical endocrinology and metabolism, 2010, Volume: 95, Issue:8 Topics: Adult; Analysis of Variance; Area Under Curve; Blood Glucose; Duodenum; Electric Impedance; Female; Gastric Inhibitory Polypeptide; Gastrointestinal Motility; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Hyperglycemia; Incretins; Insulin; Male; Manometry; Single-Blind Method	2010
Weight loss and incretin responsiveness improve glucose control independently after gastric bypass surgery. Journal of diabetes, 2010, Volume: 2, Issue:1 Topics: Adiponectin; Adult; Blood Glucose; Diabetes Mellitus, Type 2; Fasting; Female; Gastric Bypass; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Humans; Incretins; Insulin; Insulin Secretion; Leptin; Middle Aged; Obesity, Morbid; Postoperative Period; Stomach; Weight Loss	2010
Distinguishing among incretin-based therapies. Glucose-lowering effects of incretin-based therapies. The Journal of family practice, 2010, Volume: 59, Issue:9 Suppl 1 Topics: Adamantane; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Female; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Incretins; Insulin; Insulin Resistance; Liraglutide; Male; Metformin; Middle Aged; Peptides; Pyrazines; Receptors, Glucagon; Sitagliptin Phosphate; Triazoles; Venoms	2010
Distinguishing among incretin-based therapies. Safety, tolerability, and nonglycemic effects of incretin-based therapies. The Journal of family practice, 2010, Volume: 59, Issue:9 Suppl 1 Topics: Adamantane; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Female; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Incretins; Insulin; Liraglutide; Male; Metformin; Middle Aged; Peptides; Pyrazines; Receptors, Glucagon; Risk; Sitagliptin Phosphate; Triazoles; Venoms; Weight Loss	2010
Distinguishing among incretin-based therapies. Patient education and self-management. The Journal of family practice, 2010, Volume: 59, Issue:9 Suppl 1 Topics: Adamantane; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Female; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Incretins; Insulin; Insulin Resistance; Liraglutide; Male; Metformin; Middle Aged; Patient Education as Topic; Peptides; Pyrazines; Receptors, Glucagon; Self Care; Sitagliptin Phosphate; Triazoles; Venoms	2010
Distinguishing among incretin-based therapies. Pathophysiology of type 2 diabetes mellitus: potential role of incretin-based therapies. The Journal of family practice, 2010, Volume: 59, Issue:9 Suppl 1 Topics: Adamantane; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptides; Exenatide; Female; Glucagon; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Incretins; Insulin-Secreting Cells; Liraglutide; Male; Metformin; Middle Aged; Peptides; Pyrazines; Severity of Illness Index; Sitagliptin Phosphate; Time Factors; Triazoles; Venoms	2010
The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes. American journal of physiology. Endocrinology and metabolism, 2011, Volume: 300, Issue:6 Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Glucose Tolerance Test; Humans; Incretins; Insulin; Insulin-Secreting Cells; Male; Middle Aged; Peptides	2011
Dual elimination of the glucagon and GLP-1 receptors in mice reveals plasticity in the incretin axis. The Journal of clinical investigation, 2011, Volume: 121, Issue:5 Topics: Animals; Cholecystokinin; Glucagon; Glucagon-Like Peptide-1 Receptor; Glucose Tolerance Test; Incretins; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Oxygen Consumption; Pancreas; Phenotype; Rats; Receptors, Glucagon	2011
Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity. Diabetes, obesity & metabolism, 2012, Volume: 14, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Blood Glucose; Body Mass Index; C-Peptide; Diabetes Mellitus, Type 2; Fasting; Female; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Tolerance Test; Humans; Incretins; Insulin; Insulin-Secreting Cells; Male; Middle Aged; Obesity	2012
A pilot study of the efficacy of miglitol and sitagliptin for type 2 diabetes with a continuous glucose monitoring system and incretin-related markers. Cardiovascular diabetology, 2011, Dec-22, Volume: 10 Topics: 1-Deoxynojirimycin; Aged; Biomarkers; Blood Glucose; Case-Control Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemic Agents; Incretins; Insulin; Male; Middle Aged; Monitoring, Physiologic; Pilot Projects; Postprandial Period; Pyrazines; Sitagliptin Phosphate; Triazoles	2011
Increased action of pulsatile compared to non-pulsatile insulin delivery during a meal-like glucose exposure simulated by computerized infusion in healthy humans. Metabolism: clinical and experimental, 2012, Volume: 61, Issue:8 Topics: Adult; Biomarkers; Blood Glucose; C-Peptide; Computer Simulation; Diabetes Mellitus, Type 2; Eating; Fatty Acids, Nonesterified; Female; Glucagon; Human Growth Hormone; Humans; Hypoglycemic Agents; Incretins; Insulin; Insulin Infusion Systems; Insulin Secretion; Male; Pancreatic Hormones; Pituitary Hormones; Postprandial Period; Pulsatile Flow; Research Design; Time Factors	2012
MK-626, a dipeptidyl peptidase-4 inhibitor, does not improve the hyperglycemia or hyperinsulinemia of nonobese diabetic MKR mice. Canadian journal of physiology and pharmacology, 2012, Volume: 90, Issue:5 Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Dipeptidyl-Peptidase IV Inhibitors; Glucagon; Glucose; Glucose Intolerance; Homeostasis; Hyperglycemia; Hyperinsulinism; Incretins; Insulin; Insulin Secretion; Islets of Langerhans; Male; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, Obese; Phenylalanine; Triazoles	2012
Incretin and pancreatic hormone secretion in Caucasian non-diabetic carriers of the TCF7L2 rs7903146 risk T allele. Diabetes, obesity & metabolism, 2013, Volume: 15, Issue:1 Topics: Alleles; Blood Glucose; Female; Gastric Inhibitory Polypeptide; Genotype; Glucagon; Glucagon-Like Peptide 1; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Incretins; Insulin; Male; Middle Aged; Transcription Factor 7-Like 2 Protein; White People	2013
Activation of enteroendocrine membrane progesterone receptors promotes incretin secretion and improves glucose tolerance in mice. Diabetes, 2013, Volume: 62, Issue:1 Topics: Animals; Enteroendocrine Cells; Extracellular Signal-Regulated MAP Kinases; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Homeostasis; Incretins; Male; Mice; Mice, Inbred C57BL; Phosphorylation; Promegestone; Receptors, Progesterone	2013
Impact of incretin on early-phase insulin secretion and glucose excursion. Endocrine, 2013, Volume: 44, Issue:2 Topics: Adult; Blood Glucose; Cohort Studies; Diabetes Mellitus, Type 2; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Intolerance; Glucose Tolerance Test; Humans; Incretins; Insulin; Insulin Secretion; Male; Middle Aged	2013
Gastrointestinal factors contribute to glucometabolic disturbances in nondiabetic patients with end-stage renal disease. Kidney international, 2013, Volume: 83, Issue:5 Topics: Adult; Analysis of Variance; Area Under Curve; Biomarkers; Blood Glucose; Case-Control Studies; Fasting; Female; Gastric Inhibitory Polypeptide; Gastrointestinal Tract; Glucagon; Glucagon-Like Peptide 1; Glucose Metabolism Disorders; Glucose Tolerance Test; Humans; Incretins; Insulin; Kidney Failure, Chronic; Linear Models; Male; Middle Aged; Time Factors	2013
The incretin effect in Korean subjects with normal glucose tolerance or type 2 diabetes. Clinical endocrinology, 2014, Volume: 80, Issue:2 Topics: Adult; Asian People; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Humans; Incretins; Insulin; Insulin Secretion; Male; Middle Aged; Republic of Korea	2014
Preserved GLP-1 and exaggerated GIP secretion in type 2 diabetes and relationships with triglycerides and ALT. European journal of endocrinology, 2013, Volume: 169, Issue:4 Topics: Adult; Aged; Alanine Transaminase; Area Under Curve; Biomarkers; Diabetes Mellitus, Type 2; Eating; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Tolerance Test; Humans; Incretins; Lipid Metabolism; Male; Middle Aged; Triglycerides	2013
Postprandial responses of incretin and pancreatic hormones in non-diabetic patients with end-stage renal disease. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2014, Volume: 29, Issue:1 Topics: Adult; Blood Glucose; Female; Gastric Emptying; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Incretins; Insulin; Kidney Failure, Chronic; Male; Middle Aged; Pancreatic Hormones; Postprandial Period	2014
Glucagon response to oral glucose challenge in type 1 diabetes: lack of impact of euglycemia. Diabetes care, 2014, Volume: 37, Issue:4 Topics: Blood Glucose; Carbohydrate Metabolism, Inborn Errors; Diabetes Mellitus, Type 1; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Tolerance Test; Glycerol Kinase; Humans; Hypoadrenocorticism, Familial; Incretins; Male; Middle Aged	2014
Intracerebroventricular administration of novel glucagon-like peptide suppresses food intake in chicks. Peptides, 2014, Volume: 52 Topics: Animals; Appetite Depressants; Blood Glucose; Brain; Chickens; Corticosterone; Eating; Glucagon; Glucagon-Like Peptide 1; Incretins; Male; Oxyntomodulin; Receptors, Corticotropin-Releasing Hormone	2014
Alpha- and beta-cell abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes. Acta diabetologica, 2014, Volume: 51, Issue:4 Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucagon; Glucagon-Secreting Cells; Glycated Hemoglobin; Humans; Incretins; Insulin; Insulin-Secreting Cells; Male; Middle Aged; Prediabetic State	2014
GLP-1 at physiological concentrations recruits skeletal and cardiac muscle microvasculature in healthy humans. Clinical science (London, England : 1979), 2014, Volume: 127, Issue:3 Topics: Adolescent; Adult; Blood Flow Velocity; Blood Volume; Coronary Vessels; Glucagon; Glucagon-Like Peptide 1; Humans; Incretins; Microvessels; Muscle, Skeletal; Regional Blood Flow	2014
Incretin effect and glucagon responses to oral and intravenous glucose in patients with maturity-onset diabetes of the young--type 2 and type 3. Diabetes, 2014, Volume: 63, Issue:8 Topics: Administration, Intravenous; Administration, Oral; Adult; Diabetes Mellitus, Type 2; Female; Gastric Emptying; Gastric Inhibitory Polypeptide; Gene Expression Regulation; Glucagon; Glucagon-Like Peptide 1; Glucokinase; Glucose; Hepatocyte Nuclear Factor 1-alpha; Humans; Incretins; Insulin Resistance; Male; Middle Aged	2014
Small intestinal glucose exposure determines the magnitude of the incretin effect in health and type 2 diabetes. Diabetes, 2014, Volume: 63, Issue:8 Topics: Animals; Blood Glucose; Body Mass Index; C-Peptide; Case-Control Studies; Diabetes Mellitus, Type 2; Gastric Inhibitory Polypeptide; Gene Expression Regulation; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Incretins; Insulin; Male	2014
Generation of high-yield insulin producing cells from human bone marrow mesenchymal stem cells. Molecular biology reports, 2014, Volume: 41, Issue:7 Topics: Activins; Basic Helix-Loop-Helix Transcription Factors; Biomarkers; Bone Marrow Cells; Cell Differentiation; Cells, Cultured; Culture Media; Exenatide; Gene Expression; Glucagon; Hepatocyte Growth Factor; Hepatocyte Nuclear Factor 3-beta; Homeobox Protein Nkx-2.2; Homeodomain Proteins; Humans; Incretins; Insulin; Insulin-Secreting Cells; Mesenchymal Stem Cells; Nerve Tissue Proteins; Nuclear Proteins; Peptides; Somatostatin; SOXF Transcription Factors; Taurine; Trans-Activators; Transcription Factors; Venoms; Zebrafish Proteins	2014
Diabetes. Attenuated incretin effect after glucose loading in monogenic HNF1A diabetes. Nature reviews. Endocrinology, 2014, Volume: 10, Issue:6 Topics: Diabetes Mellitus, Type 2; Female; Glucagon; Glucose; Humans; Incretins; Male	2014
Meal feeding improves oral glucose tolerance in male rats and causes adaptations in postprandial islet hormone secretion that are independent of plasma incretins or glycemia. American journal of physiology. Endocrinology and metabolism, 2014, Nov-01, Volume: 307, Issue:9 Topics: Allostasis; Animals; Behavior, Animal; Feeding Behavior; Gastric Inhibitory Polypeptide; Glucagon; Glucose Intolerance; Hyperglycemia; Ileum; Incretins; Insulin; Insulin Secretion; Intestinal Mucosa; Islets of Langerhans; Jejunum; Male; Meals; Neurosecretory Systems; Organ Specificity; Postprandial Period; Proglucagon; Rats, Long-Evans	2014
[The physiology of glucagon-like peptide-1 and its role in the pathophysiology of type 2 diabetes mellitus]. Medicina clinica, 2014, Volume: 143 Suppl 2 Topics: Animals; Blood Glucose; Carbohydrate Metabolism, Inborn Errors; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Eating; Gastric Emptying; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose; Homeostasis; Humans; Hyperglycemia; Incretins; Insulin; Insulin Secretion; Insulin-Secreting Cells; Malabsorption Syndromes; Mice; Mice, Knockout; Models, Biological; Obesity; Receptors, Glucagon	2014
Functional consequences of glucagon-like peptide-1 receptor cross-talk and trafficking. The Journal of biological chemistry, 2015, Jan-09, Volume: 290, Issue:2 Topics: Diabetes Mellitus, Type 2; Dynamin I; Gastric Inhibitory Polypeptide; Gene Expression Regulation; Glucagon; Glucagon-Like Peptide-1 Receptor; HEK293 Cells; Humans; Incretins; Islets of Langerhans; Ligands; Protein Transport; Receptors, G-Protein-Coupled; Receptors, Glucagon; Signal Transduction	2015
Incretin secretion in obese Korean children and adolescents with newly diagnosed type 2 diabetes. Clinical endocrinology, 2016, Volume: 84, Issue:1 Topics: Adolescent; Analysis of Variance; Asian People; Blood Glucose; Body Mass Index; C-Peptide; Case-Control Studies; Child; Diabetes Mellitus, Type 2; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Humans; Incretins; Insulin; Insulin Resistance; Male; Obesity; Republic of Korea	2016
Impaired incretin effect is an early sign of glucose dysmetabolism in nondiabetic patients with psoriasis. Journal of internal medicine, 2015, Volume: 278, Issue:6 Topics: Adult; Aged; Diabetes Mellitus, Type 2; Female; Gastrointestinal Tract; Glucagon; Glucose; Glucose Tolerance Test; Humans; Incretins; Insulin; Insulin-Secreting Cells; Male; Middle Aged; Prediabetic State; Psoriasis; Reproducibility of Results; Severity of Illness Index	2015
Degradation and Stabilization of Peptide Hormones in Human Blood Specimens. PloS one, 2015, Volume: 10, Issue:7 Topics: Amino Acid Sequence; Dipeptidyl Peptidase 4; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Incretins; Molecular Sequence Data; Oxyntomodulin; Peptide Fragments; Peptide Hormones; Protein Stability; Proteolysis; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization	2015
Mixed meal ingestion diminishes glucose excursion in comparison with glucose ingestion via several adaptive mechanisms in people with and without type 2 diabetes. Diabetes, obesity & metabolism, 2016, Volume: 18, Issue:1 Topics: Acetaminophen; Adult; Aged; Analgesics, Non-Narcotic; Blood Glucose; C-Peptide; Case-Control Studies; Diabetes Mellitus, Type 2; Dietary Fats; Dietary Proteins; Female; Gastric Emptying; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Healthy Volunteers; Humans; Incretins; Insulin; Insulin-Secreting Cells; Male; Meals; Middle Aged; Postprandial Period	2016
Localization of dipeptidyl peptidase-4 (CD26) to human pancreatic ducts and islet alpha cells. Diabetes research and clinical practice, 2015, Volume: 110, Issue:3 Topics: Adult; Aged; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Female; Glucagon; Glucagon-Like Peptide 1; Glucagon-Secreting Cells; Humans; Immunohistochemistry; Incretins; Insulin-Secreting Cells; Male; Middle Aged; Pancreatic Ducts; Proinsulin; Young Adult	2015
The effect of 8 days of strict bed rest on the incretin effect in healthy volunteers. Journal of applied physiology (Bethesda, Md. : 1985), 2016, Mar-15, Volume: 120, Issue:6 Topics: Adolescent; Adult; Bed Rest; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Gastric Inhibitory Polypeptide; Glucagon; Glucose; Glucose Tolerance Test; Healthy Volunteers; Humans; Incretins; Insulin; Insulin Resistance; Male; Young Adult	2016
Autophagy deficiency in β cells blunts incretin-induced suppression of glucagon release from α cells. Islets, 2015, Volume: 7, Issue:5 Topics: Animals; Autophagy; Diabetes Mellitus, Experimental; Glucagon; Glucagon-Secreting Cells; Glucose Intolerance; Incretins; Insulin-Secreting Cells; Islets of Langerhans; Male; Mice	2015
Differential Effects of Oral and Intravenous Lipid Administration on Key Molecules Related to Energy Homeostasis. The Journal of clinical endocrinology and metabolism, 2016, Volume: 101, Issue:5 Topics: Adiponectin; Administration, Oral; Adult; alpha-2-HS-Glycoprotein; Blood Glucose; C-Peptide; Cytokines; Energy Metabolism; Fatty Acids, Nonesterified; Female; Fibroblast Growth Factors; Fibronectins; Ghrelin; Glucagon; GPI-Linked Proteins; Homeostasis; Humans; Incretins; Infusions, Intravenous; Insulin; Lectins; Lipids; Male; Middle Aged; Peptide YY; Young Adult	2016
The Shape of the Glucose Response Curve During an Oral Glucose Tolerance Test Heralds Biomarkers of Type 2 Diabetes Risk in Obese Youth. Diabetes care, 2016, Volume: 39, Issue:8 Topics: Adiposity; Adolescent; Biomarkers; Blood Glucose; Body Composition; Body Mass Index; C-Peptide; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Incretins; Insulin; Insulin Secretion; Male; Pediatric Obesity; Risk Factors	2016
Reduced β-Cell Secretory Capacity in Pancreatic-Insufficient, but Not Pancreatic-Sufficient, Cystic Fibrosis Despite Normal Glucose Tolerance. Diabetes, 2017, Volume: 66, Issue:1 Topics: Adolescent; Adult; C-Peptide; Cystic Fibrosis; Exocrine Pancreatic Insufficiency; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Tolerance Test; Humans; Incretins; Insulin; Insulin-Secreting Cells; Male; Middle Aged; Pancreas; Proinsulin; Young Adult	2017
Histological changes in endocrine and exocrine pancreatic tissue from patients exposed to incretin-based therapies. Diabetes, obesity & metabolism, 2016, Volume: 18, Issue:12 Topics: Acinar Cells; Adamantane; Adenocarcinoma; Adult; Aged; Carcinoma in Situ; Case-Control Studies; Cystadenoma; Diabetes Mellitus, Type 2; Digestive System Surgical Procedures; Dipeptides; Exenatide; Female; Glucagon; Glucagon-Secreting Cells; Humans; Incretins; Insulin; Insulin-Secreting Cells; Islets of Langerhans; Male; Middle Aged; Neuroendocrine Tumors; Nitriles; Organ Size; Pancreas; Pancreas, Exocrine; Pancreatic Neoplasms; Pancreatitis, Chronic; Peptides; Pyrrolidines; Sitagliptin Phosphate; Tissue Donors; Venoms; Vildagliptin	2016
Acute Reduction of Incretin Effect and Glucose Intolerance in Rats by Single Intragastric Administration of 3-deoxyglucosone. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2017, Volume: 125, Issue:1 Topics: Animals; Cyclic AMP; Deoxyglucose; Glucagon; Glucagon-Like Peptide 1; Glucose Intolerance; Incretins; Insulin; Male; Mice; Prediabetic State; Rats	2017
Immunohistochemical assessment of glucagon-like peptide 1 receptor (GLP-1R) expression in the pancreas of patients with type 2 diabetes. Diabetes, obesity & metabolism, 2017, Volume: 19, Issue:5 Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibody Specificity; Biomarkers; Diabetes Mellitus, Type 2; Female; Glucagon; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Image Processing, Computer-Assisted; Immunohistochemistry; Incretins; Insulin; Insulin-Secreting Cells; Male; Middle Aged; Pancreas; Tissue Banks; Young Adult	2017
β-Cell Inactivation of Diabetes, 2017, Volume: 66, Issue:6 Topics: Adipokines; Animals; Apoptosis; Blood Glucose; Diabetes Mellitus, Experimental; Diet, High-Fat; Gene Expression Profiling; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Tolerance Test; Incretins; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Male; Mice, Knockout; Oxadiazoles; Pyrimidines; Receptors, G-Protein-Coupled	2017
Pancreas and Not Gut Mediates the GLP-1-Induced Glucoincretin Effect. Cell metabolism, 2017, 04-04, Volume: 25, Issue:4 Topics: Animals; Glucagon; Glucagon-Like Peptide 1; Incretins; Insulin; Mice; Pancreas; Peptide Fragments	2017
GLP-1 and GIP Levels in Patients With Hyperthyroidism: The Effect of Antithyroid Treatment. The Annals of pharmacotherapy, 2017, Volume: 51, Issue:8 Topics: Adult; Antithyroid Agents; Blood Glucose; Case-Control Studies; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Humans; Hyperthyroidism; Incretins; Insulin; Male; Middle Aged	2017
Development of a UHPLC-MS/MS (SRM) method for the quantitation of endogenous glucagon and dosed GLP-1 from human plasma. Bioanalysis, 2017, Volume: 9, Issue:9 Topics: Chromatography, High Pressure Liquid; Glucagon; Glucagon-Like Peptide 1; Humans; Incretins; Limit of Detection; Tandem Mass Spectrometry	2017
Increased Incretin But Not Insulin Response after Oral versus Intravenous Branched Chain Amino Acids. Annals of nutrition & metabolism, 2017, Volume: 70, Issue:4 Topics: Administration, Intravenous; Administration, Oral; Adult; Amino Acids, Branched-Chain; Blood Glucose; C-Peptide; Dose-Response Relationship, Drug; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Incretins; Insulin; Isoleucine; Leucine; Male; Valine; Young Adult	2017
Comparative effects of intraduodenal fat and glucose on the gut-incretin axis in healthy males. Peptides, 2017, Volume: 95 Topics: Adult; Blood Glucose; Duodenum; Gastric Inhibitory Polypeptide; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptide 1; Glucose; Healthy Volunteers; Humans; Incretins; Insulin; Insulin Secretion; Intestine, Small; Male; Postprandial Period	2017
Rebirth of the Incretin Concept: Its conception and early development. Peptides, 2018, Volume: 100 Topics: Blood Glucose; Diabetes Mellitus, Type 2; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Hyperglycemia; Incretins; Insulin; Peptide Fragments	2018
Incretins and Their Endocrine and Metabolic Functions. Endocrine development, 2017, Volume: 32 Topics: Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Gastrointestinal Tract; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucagon-Secreting Cells; Glucose; Humans; Hypoglycemic Agents; Incretins; Insulin; Insulin Secretion; Insulin-Secreting Cells	2017
GPR40 partial agonists and AgoPAMs: Differentiating effects on glucose and hormonal secretions in the rodent. PloS one, 2017, Volume: 12, Issue:10 Topics: Animals; Cell Line; CHO Cells; Cricetulus; Glucagon; Glucose; Glucose Tolerance Test; Humans; Incretins; Insulin; Insulin Secretion; Islets of Langerhans; Male; Mice; Rats; Receptors, G-Protein-Coupled	2017
Diabetes care, 2018, Volume: 41, Issue:3 Topics: Adult; Aged; Alleles; Blood Glucose; Diabetes Mellitus, Type 2; Female; Genotyping Techniques; Glipizide; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Humans; Incretins; Male; Metformin; Middle Aged; Polymorphism, Single Nucleotide; Prospective Studies; Retrospective Studies; Risk Factors; Sulfonylurea Compounds; Transcription Factor 7-Like 2 Protein	2018
Common variants in the hERG (KCNH2) voltage-gated potassium channel are associated with altered fasting and glucose-stimulated plasma incretin and glucagon responses. BMC genetics, 2018, 03-16, Volume: 19, Issue:1 Topics: Aged; Cohort Studies; Denmark; ERG1 Potassium Channel; Fasting; Female; Gain of Function Mutation; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Tolerance Test; Humans; Incretins; Long QT Syndrome; Male; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors	2018
Altered pancreatic islet morphology and function in SGLT1 knockout mice on a glucose-deficient, fat-enriched diet. Molecular metabolism, 2018, Volume: 13 Topics: Animals; Blood Glucose; Diet, High-Fat; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Secreting Cells; Glucose; Incretins; Insulin; Insulin-Secreting Cells; Islets of Langerhans; Mice; Mice, Knockout; Pancreas; Sodium-Glucose Transporter 1	2018
Preventive treatment with liraglutide protects against development of glucose intolerance in a rat model of Wolfram syndrome. Scientific reports, 2018, 07-05, Volume: 8, Issue:1 Topics: Animals; Blood Glucose; Calmodulin-Binding Proteins; Disease Models, Animal; Endoplasmic Reticulum Stress; Gene Knockout Techniques; Glucagon; Glucagon-Like Peptide-1 Receptor; Glucose Intolerance; Glucose Tolerance Test; Humans; Incretins; Injections, Subcutaneous; Insulin; Islets of Langerhans; Liraglutide; Male; Membrane Proteins; Rats; Rats, Transgenic; Treatment Outcome; Wolfram Syndrome	2018
Periodontitis affects glucoregulatory hormones in severely obese individuals. International journal of obesity (2005), 2019, Volume: 43, Issue:5 Topics: Adult; Blood Glucose; Cross-Sectional Studies; Female; Gastric Inhibitory Polypeptide; Glucagon; Humans; Incretins; Insulin; Male; Middle Aged; Obesity, Morbid; Periodontitis	2019
Inappropriate glucagon and GLP-1 secretion in individuals with long-standing type 1 diabetes: effects of residual C-peptide. Diabetologia, 2019, Volume: 62, Issue:4 Topics: Adult; Area Under Curve; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Female; Glucagon; Glucagon-Like Peptide 1; Glucagon-Secreting Cells; Glucose Tolerance Test; Humans; Incretins; Insulin; Insulin-Secreting Cells; Male; Young Adult	2019
Role of vagal activation in postprandial glucose metabolism after gastric bypass in individuals with and without hypoglycaemia. Diabetes, obesity & metabolism, 2019, Volume: 21, Issue:6 Topics: Blood Glucose; Gastric Bypass; Glucagon; Humans; Hypoglycemia; Incretins; Insulin; Postprandial Period; Vagus Nerve	2019
Bile Modulates Secretion of Incretins and Insulin: A Study of Human Extrahepatic Cholestasis. The Journal of clinical endocrinology and metabolism, 2019, 07-01, Volume: 104, Issue:7 Topics: Ampulla of Vater; Bariatric Surgery; Bile; Bile Acids and Salts; Bilirubin; Blood Glucose; Cholestasis, Extrahepatic; Diabetes Mellitus, Type 2; Duodenal Neoplasms; Fasting; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Incretins; Insulin; Insulin Secretion; Male; Middle Aged; Pancreaticoduodenectomy; Postprandial Period	2019
Glucose-dependent Insulinotropic Polypeptide (GIP) Resistance and β-cell Dysfunction Contribute to Hyperglycaemia in Acromegaly. Scientific reports, 2019, 04-04, Volume: 9, Issue:1 Topics: Acromegaly; Adult; Blood Glucose; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Clamp Technique; Humans; Hyperglycemia; Incretins; Insulin; Insulin Resistance; Insulin-Secreting Cells; Male; Prospective Studies; Receptors, Gastrointestinal Hormone	2019
Dysregulated insulin in pancreatic insufficient cystic fibrosis with post-prandial hypoglycemia. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2020, Volume: 19, Issue:2 Topics: Adolescent; Area Under Curve; Blood Glucose; C-Peptide; Cystic Fibrosis; Exocrine Pancreatic Insufficiency; Female; Glucagon; Glucose Intolerance; Glucose Tolerance Test; Humans; Hypoglycemia; Incretins; Insulin; Insulin Secretion; Male; Young Adult	2020
Incretins in fibrocalculous pancreatic diabetes: A unique subtype of pancreatogenic diabetes. Journal of diabetes, 2021, Volume: 13, Issue:6 Topics: Adolescent; Adult; Biomarkers; Blood Glucose; C-Peptide; Calcinosis; Case-Control Studies; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Female; Fibrosis; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Incretins; Insulin; Male; Middle Aged; Pancreatitis, Chronic; Time Factors; Young Adult	2021
GIP mediates the incretin effect and glucose tolerance by dual actions on α cells and β cells. Science advances, 2021, Volume: 7, Issue:11 Topics: Diabetes Mellitus, Type 2; Gastric Inhibitory Polypeptide; Glucagon; Glucose; Humans; Incretins; Receptors, G-Protein-Coupled; Receptors, Gastrointestinal Hormone	2021
Whey protein preload enhances the active GLP-1 response and reduces circulating glucose in women with polycystic ovarian syndrome. Nutrition research (New York, N.Y.), 2021, Volume: 92 Topics: Adolescent; Adult; Analysis of Variance; Area Under Curve; Blood Glucose; Case-Control Studies; Diabetes Mellitus, Type 2; Dietary Proteins; Dietary Supplements; Female; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Humans; Hyperglycemia; Incretins; Insulin; Polycystic Ovary Syndrome; Postprandial Period; Whey Proteins; Young Adult	2021
The sugar-responsive enteroendocrine neuropeptide F regulates lipid metabolism through glucagon-like and insulin-like hormones in Drosophila melanogaster. Nature communications, 2021, 08-10, Volume: 12, Issue:1 Topics: Animals; Animals, Genetically Modified; Drosophila melanogaster; Enteroendocrine Cells; Female; Glucagon; Glucagon-Like Peptide 1; Hormones; Humans; Hypoglycemia; Incretins; Insulin; Insulin Secretion; Lipid Metabolism; Mutation; Neuropeptides; Receptors, Neuropeptide; Sugars	2021
Impact of the different biliopancreatic limb length on diabetes and incretin hormone secretion following distal gastrectomy in gastric cancer patients. Scientific reports, 2021, 11-17, Volume: 11, Issue:1 Topics: Aged; Anastomosis, Roux-en-Y; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Gastrectomy; Gastric Bypass; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Humans; Incretins; Insulin; Male; Middle Aged; Postoperative Period; Prospective Studies; Stomach Neoplasms; Treatment Outcome	2021
Effects of luseogliflozin on the secretion of islet hormones and incretins in patients with type 2 diabetes. Endocrine journal, 2022, Jun-28, Volume: 69, Issue:6 Topics: Blood Glucose; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Hypoglycemic Agents; Incretins; Sorbitol	2022
The alpha-7 nicotinic acetylcholine receptor agonist GTS-21 engages the glucagon-like peptide-1 incretin hormone axis to lower levels of blood glucose in db/db mice. Diabetes, obesity & metabolism, 2022, Volume: 24, Issue:7 Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzylidene Compounds; Blood Glucose; Diabetes Mellitus, Type 2; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose Tolerance Test; Humans; Incretins; Insulin; Insulin Resistance; Male; Mice; Mice, Knockout; Nicotinic Agonists; Pyridines; Sitagliptin Phosphate; Tyrosine	2022
Incretin Response to Mixed Meal Challenge in Active Cushing's Disease and after Pasireotide Therapy. International journal of molecular sciences, 2022, May-06, Volume: 23, Issue:9 Topics: Blood Glucose; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Incretins; Insulin; Insulin Resistance; Meals; Pituitary ACTH Hypersecretion; Somatostatin	2022
Comparison of Hormonal Response to a Mixed-Meal Challenge in Hypoglycemia After Sleeve Gastrectomy vs Gastric Bypass. The Journal of clinical endocrinology and metabolism, 2022, 09-28, Volume: 107, Issue:10 Topics: Blood Glucose; Female; Gastrectomy; Gastric Bypass; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Hypoglycemia; Incretins; Insulin; Male; Middle Aged; Obesity, Morbid	2022
The Cytoskeletal Transport Protein, Secretagogin, Is Essential for Diurnal Glucagon-like Peptide-1 Secretion in Mice. Endocrinology, 2022, 10-11, Volume: 163, Issue:11 Topics: Actins; Animals; Carrier Proteins; Glucagon; Glucagon-Like Peptide 1; Glucose; Incretins; Insulin; Mice; Proteasome Endopeptidase Complex; Secretagogins	2022
Metabolic Dysregulation in Adult Survivors of Pediatric Hematopoietic Stem Cell Transplantation: The Role of Incretins. The Journal of clinical endocrinology and metabolism, 2023, 01-17, Volume: 108, Issue:2 Topics: Adult; Blood Glucose; Child; Cross-Sectional Studies; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Hematopoietic Stem Cell Transplantation; Humans; Incretins; Insulin; Male; Metabolic Syndrome; Survivors	2023
SMALL INTESTINAL L CELL DENSITY IN PATIENTS WITH SEVERE OBESITY AFTER ROUX-EN-Y GASTRIC BYPASS. Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery, 2022, Volume: 35 Topics: Anastomosis, Roux-en-Y; Diabetes Mellitus, Type 2; Enteroendocrine Cells; Gastric Bypass; Glucagon; Humans; Incretins; Obesity, Morbid; Treatment Outcome	2022
Multi-action Secretagogin Controls Circadian Glucagon-Like Peptide-1 Secretion. Endocrinology, 2022, 10-23, Volume: 163, Issue:12 Topics: Animals; Carrier Proteins; Glucagon; Glucagon-Like Peptide 1; Incretins; Mice; Secretagogins	2022
Implication of sugar, protein and incretins in excessive glucagon secretion in type 2 diabetes after mixed meals. Clinical nutrition (Edinburgh, Scotland), 2023, Volume: 42, Issue:4 Topics: Blood Glucose; Caseins; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; Humans; Incretins; Insulin; Meals; Obesity; Sucrose; Sugars	2023
Alterations of adipokines, pancreatic hormones and incretins in acute and convalescent COVID-19 children. BMC pediatrics, 2023, 04-03, Volume: 23, Issue:1 Topics: Adipokines; Adiponectin; C-Peptide; Child; Complement Factor D; COVID-19; Cytokines; Diabetes Mellitus, Type 2; Ghrelin; Glucagon; Granulocyte Colony-Stimulating Factor; Humans; Incretins; Interleukin-12; Interleukin-17; Interleukin-6; Leptin; Pancreatic Hormones; SARS-CoV-2; Tumor Necrosis Factor-alpha	2023
Designer GLP1 poly-agonist peptides in the management of diabesity. Expert review of endocrinology & metabolism, 2023, Volume: 18, Issue:3 Topics: Diabetes Mellitus, Type 2; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Incretins	2023
Incretin hormone responses to carbohydrate and protein/fat are preserved in adults with sulfonylurea-treated KCNJ11 neonatal diabetes. Journal of diabetes investigation, 2023, Volume: 14, Issue:12 Topics: Adult; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Incretins; Infant, Newborn; Insulin	2023
Glucagon as the First Incretin: Objects (in the Rearview Mirror) Are Closer Than They Appear. Diabetes, 2023, Dec-01, Volume: 72, Issue:12 Topics: Blood Glucose; Diabetes Mellitus, Type 2; Gastric Inhibitory Polypeptide; Glucagon; Humans; Incretins; Insulin	2023